Bank Of New York Mellon Corp Reata Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $2.26 Million - $4.29 Million	101,952 New	101,952 $3.87 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $137,248 - $258,020	7,071 Added 7.66%	99,379 $2.5 Million
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $587,480 - $1.04 Million	-28,367 Reduced 23.51%	92,308 $2.81 Million
Q1 2022 May 11, 2022	BUY	$24.12 - $39.6 $46,479 - $76,309	1,927 Added 1.62%	120,675 $3.95 Million
Q4 2021 Feb 11, 2022	SELL	$25.61 - $110.96 $164,416 - $712,363	-6,420 Reduced 5.13%	118,748 $3.13 Million
Q3 2021 Nov 12, 2021	BUY	$100.0 - $143.02 $599,900 - $857,976	5,999 Added 5.03%	125,168 $12.6 Million
Q2 2021 Aug 11, 2021	BUY	$78.27 - $151.29 $1.88 Million - $3.64 Million	24,079 Added 25.32%	119,169 $16.9 Million
Q1 2021 May 13, 2021	SELL	$94.25 - $132.81 $122,148 - $172,121	-1,296 Reduced 1.34%	95,090 $9.48 Million
Q4 2020 Feb 09, 2021	BUY	$102.03 - $184.62 $286,296 - $518,043	2,806 Added 3.0%	96,386 $11.9 Million
Q3 2020 Nov 12, 2020	SELL	$93.53 - $163.34 $440,339 - $769,004	-4,708 Reduced 4.79%	93,580 $9.12 Million
Q2 2020 Aug 12, 2020	SELL	$126.3 - $176.56 $2.59 Million - $3.62 Million	-20,526 Reduced 17.28%	98,288 $15.3 Million
Q1 2020 May 06, 2020	SELL	$124.16 - $247.74 $604,410 - $1.21 Million	-4,868 Reduced 3.94%	118,814 $17.1 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $1.33 Million - $3.9 Million	17,878 Added 16.9%	123,682 $25.3 Million
Q3 2019 Nov 07, 2019	SELL	$71.26 - $95.75 $551,196 - $740,626	-7,735 Reduced 6.81%	105,804 $8.5 Million
Q2 2019 Aug 12, 2019	BUY	$77.72 - $94.35 $758,158 - $920,384	9,755 Added 9.4%	113,539 $10.7 Million
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $715,285 - $1.4 Million	13,782 Added 15.31%	103,784 $8.87 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $76.44 $237,900 - $372,950	-4,879 Reduced 5.14%	90,002 $5.05 Million
Q3 2018 Nov 09, 2018	BUY	$35.64 - $92.06 $1.04 Million - $2.7 Million	29,294 Added 44.66%	94,881 $0
Q2 2018 Aug 06, 2018	BUY	$19.94 - $40.96 $328,471 - $674,734	16,473 Added 33.54%	65,587 $2.29 Million
Q1 2018 May 15, 2018	BUY	$20.0 - $30.19 $39,000 - $58,870	1,950 Added 4.13%	49,114 $1.01 Million
Q4 2017 Feb 09, 2018	BUY	$22.39 - $33.27 $1.06 Million - $1.57 Million	47,164	47,164 $1.34 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account